Cargando…

Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study

BACKGROUND: Administration of anticoagulant citrate and dextrose (ACD-A) chelates ionized calcium in blood and causes hypocalcemia in plateletpheresis donors. The aim of the study was to observe the effects of oral calcium (Ca) supplementation during plateletpheresis on various parameters related to...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Prashant Kumar, Tiwari, Aseem, Agarwal, Nitin, Dara, Ravi C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607974/
https://www.ncbi.nlm.nih.gov/pubmed/33162700
http://dx.doi.org/10.4103/ajts.AJTS_114_17
_version_ 1783604748087197696
author Pandey, Prashant Kumar
Tiwari, Aseem
Agarwal, Nitin
Dara, Ravi C.
author_facet Pandey, Prashant Kumar
Tiwari, Aseem
Agarwal, Nitin
Dara, Ravi C.
author_sort Pandey, Prashant Kumar
collection PubMed
description BACKGROUND: Administration of anticoagulant citrate and dextrose (ACD-A) chelates ionized calcium in blood and causes hypocalcemia in plateletpheresis donors. The aim of the study was to observe the effects of oral calcium (Ca) supplementation during plateletpheresis on various parameters related to calcium metabolism. MATERIALS AND METHODS: This study was performed between January 2014 and December 2014 on 200 plateletpheresis donors. They were divided into two groups. In group A donors (n=100), no prophylactic oral calcium supplementation was given. In group B (n=100) donors, 2000 mg of calcium was given one hour before the start of the procedure, 500 mg was given at the start of the procedure and 500 mg calcium was given just before the end of procedure. Biochemical parameters like serum total calcium (T Ca), serum total magnesium (T Mg) and ionized calcium level (iCa) were measured before and after the procedure. Relative risk of citrate toxicity was measured between the two groups. RESULTS: There was a significant fall in total calcium (pre 9.02 mg/dl, post 8.23 mg/dl,), ionized calcium level (pre 1.14 mmol/L, post 0.91 mmol/L) and total magnesium (pre 1.92 mg/dl, post 1.79 mg/dl) amongst the donors who did not receive prophylactic calcium supplementation. Despite calcium intake, in prophylactic calcium intake group, we did observe a significant drop in total magnesium (pre 2.04 mg/dl, post 1.94 mg/dl) and ionized calcium level (pre 1.25 mmol/L, post 1.12 mmol/L, p<0.01). We did observe a drop in total calcium level, however, this observation was not statistically significant. The risk (RR=5.44) of citrate toxicity was higher among group A donors. CONCLUSION: Prophylactic oral calcium carbonate supplementation would help in to reduce the risk of citrate toxicity. Therefore, we suggest for prophylactic oral administration of 3000 mg elemental calcium carbonate in three divided doses to make PP procedures uneventful.
format Online
Article
Text
id pubmed-7607974
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-76079742020-11-05 Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study Pandey, Prashant Kumar Tiwari, Aseem Agarwal, Nitin Dara, Ravi C. Asian J Transfus Sci Original Article BACKGROUND: Administration of anticoagulant citrate and dextrose (ACD-A) chelates ionized calcium in blood and causes hypocalcemia in plateletpheresis donors. The aim of the study was to observe the effects of oral calcium (Ca) supplementation during plateletpheresis on various parameters related to calcium metabolism. MATERIALS AND METHODS: This study was performed between January 2014 and December 2014 on 200 plateletpheresis donors. They were divided into two groups. In group A donors (n=100), no prophylactic oral calcium supplementation was given. In group B (n=100) donors, 2000 mg of calcium was given one hour before the start of the procedure, 500 mg was given at the start of the procedure and 500 mg calcium was given just before the end of procedure. Biochemical parameters like serum total calcium (T Ca), serum total magnesium (T Mg) and ionized calcium level (iCa) were measured before and after the procedure. Relative risk of citrate toxicity was measured between the two groups. RESULTS: There was a significant fall in total calcium (pre 9.02 mg/dl, post 8.23 mg/dl,), ionized calcium level (pre 1.14 mmol/L, post 0.91 mmol/L) and total magnesium (pre 1.92 mg/dl, post 1.79 mg/dl) amongst the donors who did not receive prophylactic calcium supplementation. Despite calcium intake, in prophylactic calcium intake group, we did observe a significant drop in total magnesium (pre 2.04 mg/dl, post 1.94 mg/dl) and ionized calcium level (pre 1.25 mmol/L, post 1.12 mmol/L, p<0.01). We did observe a drop in total calcium level, however, this observation was not statistically significant. The risk (RR=5.44) of citrate toxicity was higher among group A donors. CONCLUSION: Prophylactic oral calcium carbonate supplementation would help in to reduce the risk of citrate toxicity. Therefore, we suggest for prophylactic oral administration of 3000 mg elemental calcium carbonate in three divided doses to make PP procedures uneventful. Wolters Kluwer - Medknow 2020 2020-07-24 /pmc/articles/PMC7607974/ /pubmed/33162700 http://dx.doi.org/10.4103/ajts.AJTS_114_17 Text en Copyright: © 2020 Asian Journal of Transfusion Science http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Pandey, Prashant Kumar
Tiwari, Aseem
Agarwal, Nitin
Dara, Ravi C.
Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study
title Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study
title_full Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study
title_fullStr Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study
title_full_unstemmed Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study
title_short Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study
title_sort prophylactic administration of oral calcium carbonate during plateletpheresis: a bicentric prospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607974/
https://www.ncbi.nlm.nih.gov/pubmed/33162700
http://dx.doi.org/10.4103/ajts.AJTS_114_17
work_keys_str_mv AT pandeyprashantkumar prophylacticadministrationoforalcalciumcarbonateduringplateletpheresisabicentricprospectivestudy
AT tiwariaseem prophylacticadministrationoforalcalciumcarbonateduringplateletpheresisabicentricprospectivestudy
AT agarwalnitin prophylacticadministrationoforalcalciumcarbonateduringplateletpheresisabicentricprospectivestudy
AT dararavic prophylacticadministrationoforalcalciumcarbonateduringplateletpheresisabicentricprospectivestudy